Naval Daver, MD
Dr. Daver discusses immunotherapy approaches for patients with acute myeloid leukemia (AML), and his recent study results on the combination of azacitidine and nivolumab.
Jennifer Leavitt, MS, Traci DeVito, and Naveed Saleh, MD, MS
Our team reviews 2018 conference highlights in oncology care, including studies from ASH, SABCS, and SIO.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: UBM Medica, a divsion of UBM Americas
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
Naval Daver, MD
Jennifer Leavitt, MS, Traci DeVito, and Naveed Saleh, MD, MS
